Compare stocks

Vimian Group AB operates in the veterinary services industry, focusing on providing a range of specialized products and solutions for animal health. The company offers products and services across four key segments: Specialty Pharma, Diagnostics, Veterinary Services, and MedTech. These segments provide pharmaceuticals, diagnostic equipment, technology solutions, and veterinary services aimed at enhancing animal health and treatment. Founded in Sweden, Vimian Group AB is headquartered in Stockholm, from where it extends its operations globally. The company's strategic positioning is strengthened by its comprehensive range of products and services, allowing it to address diverse needs in the veterinary sector and support veterinarians through innovative solutions.

AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan added several new products and drugs in aesthetics, including Botox. The 2024 acquisitions of Cerevel (neuroscience) and ImmunoGen (oncology) help supplement AbbVie's portfolio.